Literature DB >> 12820162

Progressive degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts cognitive impairment in Alzheimer's disease: stereologic analysis of prefrontal cortex area 9.

Thierry Bussière1, Panteleimon Giannakopoulos, Constantin Bouras, Daniel P Perl, John H Morrison, Patrick R Hof.   

Abstract

We performed a stereologic analysis of a subset of pyramidal neurons known to be vulnerable in Alzheimer's disease (AD) and characterized by particularly high somatodendritic levels of nonphosphorylated neurofilament protein. In the neocortex, these large pyramidal neurons reside in the deep part of layer III (layer IIIc) and the superficial part of layer V (layer Va). We focused on prefrontal cortex area 9 in elderly control cases in comparison to cases with different degrees of cognitive dysfunction. The results confirmed that these neurons are preferentially vulnerable in AD, as their numbers decrease dramatically in cases with definite dementia, correlating strongly with the severity of the disease, to a nearly complete loss (>90%) in the endstages of AD. Furthermore, a triple-labeling experimental paradigm revealed that these particular neurons are far more likely to develop neurofibrillary tangles (NFT) and do so at a faster rate than other pyramidal cells. Nonphosphorylated neurofilament protein-rich neurons also shrink considerably during formation of NFT and the largest among them are preferentially affected. Laminar differences in the severity of these effects were observed, layer Va being more severely affected, possibly correlating with the involvement of specific cortical projections. These data reveal that different populations of neurons prone to NFT formation are lost at different rates in AD, and that nonphosphorylated neurofilament protein-enriched neurons emerge as a strikingly vulnerable subpopulation of neurons. Their preferential involvement suggests that neurons providing specific corticocortical connections between association areas are at high risk for degeneration in AD. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820162     DOI: 10.1002/cne.10760

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  65 in total

Review 1.  Dendritic vulnerability in neurodegenerative disease: insights from analyses of cortical pyramidal neurons in transgenic mouse models.

Authors:  Jennifer I Luebke; Christina M Weaver; Anne B Rocher; Alfredo Rodriguez; Johanna L Crimins; Dara L Dickstein; Susan L Wearne; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2010-02-24       Impact factor: 3.270

2.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Authors:  Miguel Angel Riudavets; Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Lee J Martin; Gay Rudow; Olga Pletnikova; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

3.  The electrotonic structure of pyramidal neurons contributing to prefrontal cortical circuits in macaque monkeys is significantly altered in aging.

Authors:  Doron Kabaso; Patrick J Coskren; Bruce I Henry; Patrick R Hof; Susan L Wearne
Journal:  Cereb Cortex       Date:  2009-01-15       Impact factor: 5.357

4.  Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex.

Authors:  Yang Yang; Constantinos D Paspalas; Lu E Jin; Marina R Picciotto; Amy F T Arnsten; Min Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

5.  Selective Neuronal Vulnerability in Alzheimer's Disease: A Network-Based Analysis.

Authors:  Jean-Pierre Roussarie; Vicky Yao; Patricia Rodriguez-Rodriguez; Rose Oughtred; Jennifer Rust; Zakary Plautz; Shirin Kasturia; Christian Albornoz; Wei Wang; Eric F Schmidt; Ruth Dannenfelser; Alicja Tadych; Lars Brichta; Alona Barnea-Cramer; Nathaniel Heintz; Patrick R Hof; Myriam Heiman; Kara Dolinski; Marc Flajolet; Olga G Troyanskaya; Paul Greengard
Journal:  Neuron       Date:  2020-06-29       Impact factor: 17.173

6.  Hippocampal neuron loss is correlated with cognitive deficits in SAMP8 mice.

Authors:  Guomin Li; Haiyan Cheng; Xuezhu Zhang; Xuemei Shang; Hui Xie; Xin Zhang; Jianchun Yu; Jingxian Han
Journal:  Neurol Sci       Date:  2012-08-08       Impact factor: 3.307

7.  Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs.

Authors:  Parvathi Rudrabhatla; Howard Jaffe; Harish C Pant
Journal:  FASEB J       Date:  2011-08-09       Impact factor: 5.191

8.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

9.  Adult neurogenesis is functionally associated with AD-like neurodegeneration.

Authors:  Qian Chen; Akira Nakajima; Se Hoon Choi; Xiaoli Xiong; Sangram S Sisodia; Ya-Ping Tang
Journal:  Neurobiol Dis       Date:  2007-11-05       Impact factor: 5.996

10.  S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.

Authors:  Weiping Qin; Lap Ho; Jun Wang; Elaine Peskind; Giulio Maria Pasinetti
Journal:  PLoS One       Date:  2009-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.